Decreased HDL-C in hidradenitis suppurativa: association with systemic inflammatory phenotype and implications for risk stratification

Hidradenitis suppurativa (HS) is a chronic inflammatory skin disorder increasingly recognized as a systemic disease with significant metabolic comorbidity. Disturbances in lipid metabolism, particularly reduced high-density lipoprotein cholesterol (HDL-C), have been consistently reported in patients with HS. However, the extent to which HDL-C levels are associated with clinical characteristics, systemic inflammatory burden, and disease severity in HS remains insufficiently defined. In this retrospective single-center study, clinical and laboratory data were analyzed for 109 patients with HS and 109 age- and sex-matched healthy controls. Serum lipid parameters were compared between groups. Patients with HS were further stratified according to HDL-C status, and differences in demographic characteristics, clinical features, and laboratory indices were examined to assess the clinical relevance of reduced HDL-C in HS. Compared with healthy controls, patients with HS had a significantly higher body mass index (BMI), triglyceride (TG) concentrations and significantly lower HDL-C levels (p < 0.001). Among patients with HS, those with abnormal HDL-C levels exhibited significantly higher BMI, white blood cell count, plateletcrit, gamma-glutamyl transferase, and high-sensitivity C-reactive protein levels than those with normal HDL-C levels (p < 0.05). In addition, axillary involvement was significantly more frequent in the abnormal HDL-C group (p = 0.017). A higher proportion of Hurley stage III disease and higher IHS4 scores were observed in the HDL-C abnormal group. Patients with HS demonstrate a characteristic reduction in HDL-C that is associated with elevated systemic inflammatory markers and increased axillary involvement. These findings support HDL-C as a readily accessible indicator of inflammatory burden and disease severity in HS and highlight its potential value in clinical risk stratification.

Authors

Institutions

Publication Details

Journal
Lipids in Health and Disease
Published
2026-04-23
DOI
https://doi.org/10.1186/s12944-026-02959-6
Primary Topic
Hidradenitis Suppurativa and Treatments
Type
article
Field-Weighted Citation Impact
0.00

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Decreased HDL-C in hidradenitis suppurativa: association with systemic inflammatory phenotype and implications for risk stratification

Y. Wang, Chao Wu, Hong-zhong Jin, Tie-jun Liu
Lipids in Health and Disease
Hidradenitis Suppurativa and Treatments
article

Decreased HDL-C in hidradenitis suppurativa: association with systemic inflammatory phenotype and implications for risk stratification

Y. Wang, Chao Wu, Hong-zhong Jin, Tie-jun Liu
article en

Abstract

Hidradenitis suppurativa (HS) is a chronic inflammatory skin disorder increasingly recognized as a systemic disease with significant metabolic comorbidity. Disturbances in lipid metabolism, particularly reduced high-density lipoprotein cholesterol (HDL-C), have been consistently reported in patients with HS. However, the extent to which HDL-C levels are associated with clinical characteristics, systemic inflammatory burden, and disease severity in HS remains insufficiently defined. In this retrospective single-center study, clinical and laboratory data were analyzed for 109 patients with HS and 109 age- and sex-matched healthy controls. Serum lipid parameters were compared between groups. Patients with HS were further stratified according to HDL-C status, and differences in demographic characteristics, clinical features, and laboratory indices were examined to assess the clinical relevance of reduced HDL-C in HS. Compared with healthy controls, patients with HS had a significantly higher body mass index (BMI), triglyceride (TG) concentrations and significantly lower HDL-C levels (p < 0.001). Among patients with HS, those with abnormal HDL-C levels exhibited significantly higher BMI, white blood cell count, plateletcrit, gamma-glutamyl transferase, and high-sensitivity C-reactive protein levels than those with normal HDL-C levels (p < 0.05). In addition, axillary involvement was significantly more frequent in the abnormal HDL-C group (p = 0.017). A higher proportion of Hurley stage III disease and higher IHS4 scores were observed in the HDL-C abnormal group. Patients with HS demonstrate a characteristic reduction in HDL-C that is associated with elevated systemic inflammatory markers and increased axillary involvement. These findings support HDL-C as a readily accessible indicator of inflammatory burden and disease severity in HS and highlight its potential value in clinical risk stratification.

Lipids in Health and Disease
Chinese Academy of Medical Sciences & Peking Union Medical College (CN), Peking Union Medical College Hospital (CN), National Cancer Center (US)
National Natural Science Foundation of China
Zero hunger
Openalex Percentile: Top 6%
Hidradenitis Suppurativa and Treatments
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.